Evolution Wealth Advisors LLC Has $3.28 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Evolution Wealth Advisors LLC boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,532 shares of the financial services provider’s stock after buying an additional 710 shares during the period. Evolution Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,281,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Blue Fin Capital Inc. boosted its stake in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak boosted its position in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. grew its holdings in shares of iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management increased its holdings in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after acquiring an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC raised its position in shares of iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 4.8 %

NASDAQ:IBB opened at $133.38 on Friday. The business’s 50-day simple moving average is $144.49 and its 200-day simple moving average is $141.59. iShares Biotechnology ETF has a fifty-two week low of $116.70 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.